by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Research into PE-22-28 represents a fascinating intersection of molecular biology, pharmacology, and translational science. This 7 amino acids compound has shown promise in areas ranging from TREK-1 inhibitor to rapid onset, making it a subject of considerable...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
The scientific community’s interest in Dihexa (Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide)) has grown steadily over the past decade. Composed of modified hexapeptide, this peptide has demonstrated notable effects in preclinical models related to memory...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Among the many peptides under active investigation, Semax stands out for its unique properties and versatile research applications. Originally studied for its effects on neuroprotection, researchers have since discovered connections to stroke recovery, BDNF increase,...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
Selank (Selank Heptapeptide) has emerged as one of the most studied peptides in modern biomedical research. With its 7 amino acids structure, this compound has attracted attention from researchers worldwide for its potential roles in tuftsin analog and immune support....
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
PE-22-28, also known as Spadin Analog PE-22-28, is a 7 amino acids peptide that has garnered significant attention in the research community. Studies have explored its potential in neurogenesis, rapid onset, and related fields, yielding a growing body of evidence that...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Research into Dihexa represents a fascinating intersection of molecular biology, pharmacology, and translational science. This modified hexapeptide compound has shown promise in areas ranging from memory enhancement to synaptogenesis, making it a subject of...
